The Valley Desk

NCT03734588 · Interventional trial

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, Factor VIII (FVIII), Factor VIII (FVIII) Deficiency, Factor VIII (FVIII) Gene, Factor VIII (FVIII) Protein, Gene Therapy, Gene Transfer, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, Hematologic Diseases, Hemorrhagic Disorders, Inhibitors, Recombinant, Vector

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov